Fairchem Organics Limited has recommended a final dividend of Re. 1 per equity share for FY26, as announced by its board on May 6, 2026, alongside the disclosure of its June 2026 quarter financial results submitted to NSE on July 27, 2026. The payout marks an 86.7% reduction from the ₹7.50 per share dividend that the company had maintained consistently for FY24 and FY25.
Dividend Details and Yield
The declared dividend of Re. 1 per equity share carries a face value context that investors must weigh against the stock's prevailing market price. With quote data unavailable at the time of publication, a precise yield calculation cannot be provided. However, given that the stock has historically traded at a significant premium to face value, the effective dividend yield on Re. 1 is expected to be well below 0.5% at most recent trading levels, compared to an approximate yield of 3% to 4% that the ₹7.50 dividend would have offered at comparable price points. Investors should verify the exact yield once the record date is confirmed by the company.
Dividend History: A Consistent Streak Now Interrupted
Fairchem Organics has maintained an unbroken dividend-paying record since listing, but the quantum has varied considerably. The historical payout trend is as follows:
- FY21: ₹3.50 per share
- FY22: ₹13.00 per share (peak payout)
- FY23: ₹7.50 per share
- FY24: ₹7.50 per share
- FY25: ₹7.50 per share
- FY26: ₹1.00 per share
The FY22 payout of ₹13 per share remains the highest in the company's history, coinciding with a period of elevated oleo-chemical margins. The three consecutive years of ₹7.50 dividends suggested a stable distribution policy, making the FY26 cut to Re. 1 a notable departure from that pattern.
Company Background
Fairchem Organics Limited is an Ahmedabad-based specialty chemicals manufacturer focused on oleo chemicals and nutraceuticals. The company derives its raw materials primarily from vegetable oil processing by-products and operates in a segment sensitive to global vegetable oil price cycles, rupee-dollar movements, and export demand from the pharmaceutical and food industries. It is listed on the NSE under the symbol FAIRCHEMOR with ISIN INE0DNW01011.
What the Q1 FY27 Results Submission Signals
The simultaneous submission of financial results for the period ended June 30, 2026 to the exchange alongside the dividend announcement provides investors with an opportunity to correlate the significantly reduced payout with underlying profitability trends. A sharp reduction in dividend of this magnitude typically reflects either compressed margins, higher capital allocation toward capex or debt repayment, or a strategic shift in the company's cash distribution policy. Without the full P and L and balance sheet figures being available in this announcement, investors are advised to review the detailed results filing on the NSE portal for revenue, EBITDA, and net profit figures before drawing conclusions.
Key Considerations for Investors
- The dividend cut from ₹7.50 to Re. 1 represents the lowest payout since FY21 and breaks a three-year stable distribution run.
- Delivery percentage and 52-week price range data were unavailable at the time of publication and should be tracked on NSE for context on institutional participation and price discovery.
- Sector PE comparison and company-specific PE metrics will become clearer once the full Q1 FY27 and FY26 annual earnings are assessed from the filed results.
- The record date and payment date for the Re. 1 dividend have not been specified in the current NSE announcement and are expected to be disclosed separately.
Investors holding or tracking FAIRCHEMOR should review the complete financial results filing on the NSE website to assess whether the dividend reduction is driven by cyclical margin pressure or a structural change in the company's capital allocation approach.